A new emergency review tool to help research ethics review during public health emergencies

Jun 07, 2010

A new emergency review tool will help research ethics boards and institutions to expedite research while respecting the procedures of ethics reviews, states an article in CMAJ (Canadian Medical Association Journal).

Pandemic (H1N1) 2009, which focused international attention on for public health threats, highlighted the need for timely research. However, there are challenges to combining speed and flexibility with intense scrutiny in conventional research ethics reviews. The (WHO) recently held a special technical consultation on research ethics in infectious disease outbreaks following international requests for guidance from research ethics committees.

"We propose a new framework to guide departures from normal research ethics review during emergencies," writes Catherine Tansey, University Health Network, Toronto General Hospital, with her coauthors. "It will be a combination of increased diligence with enhanced procedural flexibility in proportion to risks and circumstances."

The authors conclude that the emergency review may also be a useful model to improve procedures in research ethics review.

Explore further: 'Beach body' ads investigated after outcry in Britain

More information: www.cmaj.ca/cgi/doi/10.1503/cmaj.090976

Related Stories

Human Tissue Act may have helped research, says study

Sep 01, 2009

Fears that medical research using tissue such as blood or material from biopsies would be obstructed by the Human Tissue Act 2004 may have been unfounded, a new study from the University of Leicester reveals.

Nanoethics -- The watchdog of a new technology?

Jun 21, 2007

The field of nanotechnology is broad and has the potential to be used in a wide range of industries and fields, but the question is whether it is a good investment. Will it solve fundamental social problems that assure a ...

Recommended for you

Dutch DSM posts Q1 slump

Apr 29, 2015

Dutch pharmaceutical group DSM posted a 70 million euro first quarter net loss Wednesday despite an 11 percent jump in sales, boosted by higher animal nutrition volumes and favourable exchange rates.

New meds help drugmakers weather strong dollar, other issues

Apr 28, 2015

Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer Inc., Merck & Co. and Bristol-Myers Squibb ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.